Opiant Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.01-0.00-6.37-7.12-6.768.46-2.034.99-18.3349.80-3.20-6.76
Price/Sales ratio
N/AN/AN/A32.345.333.013.191.511.243.676.045.33
Price/Book Value ratio
-0.23-0.04-23.77-5.97-11.2212.852.551.680.963.195.17-11.22
Price/Cash Flow ratio
-0.13-0.05-72.77-11.82-57.7110.02-82.4814.23-16.8277.78-6.86-57.71
Price/Free Cash Flow ratio
-0.13-0.05-72.77-11.82-57.2410.02-82.4815.38-16.4077.78-6.67-57.24
Price/Earnings Growth ratio
-0.00-0.00-0.060.17-1.24-0.040.00-0.030.15-0.19-0.01-1.24
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A100%100%100%88.96%79.80%77.38%77.73%77.98%100%
Operating Profit Margin
N/AN/AN/A-445.12%-78.18%38.45%-156.81%28.53%-8.17%12.66%-179.47%38.45%
Pretax Profit Margin
N/AN/AN/A-454.05%-78.95%38.65%-156.47%29.85%-8.34%7.44%-188.10%38.65%
Net Profit Margin
N/AN/AN/A-454.05%-78.95%35.67%-156.85%30.31%-6.79%7.38%-188.47%35.67%
Effective Tax Rate
N/AN/A-1.22%1.16%0.66%7.71%-0.24%-1.55%18.61%0.80%-0.19%7.71%
Return on Assets
-27617.36%-723.96%-3819.24%-1442.79%-415.23%60.88%-72.12%28.78%-3.07%4.27%-78.87%-415.23%
Return On Equity
2007.56%470.24%373.05%83.91%166.08%151.82%-125.71%33.68%-5.24%6.42%-97.17%151.82%
Return on Capital Employed
1993.75%1785.12%678.23%223.52%328.60%106.80%-108.33%31.47%-4.13%8.10%-90.25%106.80%
Liquidity Ratios
Current Ratio
0.030.700.140.130.432.582.986.999.20N/A5.470.43
Quick Ratio
0.030.670.140.130.432.582.98195.01310.58442.495.030.43
Cash ratio
0.030.670.120.120.341.642.505.527.515.525.020.34
Days of Sales Outstanding
N/AN/AN/AN/A11.5274.20121.2668.90118.69119.440.8574.20
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A-49.86K-113.97K-119.16KN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A121.26-49.79K-113.85K-119.04K0.21N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/A277.3362.25174.73135.66294.01N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A-156.07-49.86K-114.02K-119.17K-293.16N/A
Debt Ratios
Debt Ratio
14.752.53N/A-10.860.08N/AN/A0.010.310.240.510.08
Debt Equity Ratio
-1.07-1.64N/A0.63-0.03N/AN/A0.020.530.361.04-0.03
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.000.340.260.41N/A
Total Debt to Capitalization
N/A-0.02N/A0.38-0.03N/AN/A0.020.340.260.44-0.03
Interest Coverage Ratio
-200.94-7.74-70.51-244.38-650.831.90KN/AN/A-17.10N/A-18.36-650.83
Cash Flow to Debt Ratio
N/A-29.89N/A0.79-5.54N/AN/A5.26-0.100.11-0.93-5.54
Company Equity Multiplier
-0.07-0.64-0.09-0.05-0.392.491.741.171.701.502.04-0.39
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-2.73-0.090.30-0.030.10-0.070.04-0.880.30
Free Cash Flow / Operating Cash Flow Ratio
11111.00110.921.0211.021.00
Cash Flow Coverage Ratio
N/A-29.89N/A0.79-5.54N/AN/A5.26-0.100.11-0.93-5.54
Short Term Coverage Ratio
-4.90-29.89N/A0.79-5.54N/AN/A7.86-7.185.70-7.34N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A